Personally, I think with all the different subsets of sarcoma and new chemo treatments in this trial (much more efficacious) , the placebo-arm is going to be nothing like the placebo-arm of past studies (Ariad studies and other studies), hence, a crap-shoot.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.